AURKA and hepatocellular carcinoma: To investigate the FOXM1 signaling pathway and its possible downstream proteins, including AURKA and BIRC5, in patients with HCC, the whole cohort of patients with HCC and those with Hepatitis virus infection as well as HCC were divided into high- and low-expression groups.